McAndrews Held & Malloy Attorney Christopher V. Carani to Discuss Protecting and Enforcing Medical Designs at Premier Industry Event


McAndrews, Held & Malloy Shareholder Christopher V. Carani will speak at the Industrial Designers Society of America’s (IDSA) 2015 Medical Design Conference – the premier medical design event – October 21-22, in Tampa, Fla. Given McAndrews’ long-standing focus on the medical device industry and its niche experience with design law, McAndrews is also a top-level sponsor.

At McAndrews, Carani focuses on the protection and enforcement of medical designs through the use of IP laws. At his session, “Looks Matter: Protect Your Medical Designs with Intellectual Property While Creating Valuable Assets,” on October 22, Carani will share: what aspects of medical devices can be protected by designs patents, trademarks or copyrights—including not only traditional industrial design, but also UX, graphic user interfaces and icons; how to avoid infringing other’s design-related IP rights; and how to enforce/license design-related IP rights.

Other medical design topics to be covered include:

  • Digital Health
  • Perspectives of the Healthcare Ecosystem
  • Medical Design for Aging
  • Differences in Medical Design for Developing World vs. Western Technology
  • Best Practices in Medical Design

The IDSA Medical Design Conference brings together professionals who are interested in and passionate about medical design, and in helping shape the profession as a whole, and helps them explore the usability of healthcare-related medical devices. A full list of sessions can be found here.

For more information, or to register, click here.

Christopher V. Carani, Esq., practices in all areas of intellectual property. He is a leading voice and internationally recognized in the field of Design IP (design patents, trade dress and copyrights), having litigated numerous design disputes, and published and lectured extensively on the topic. He represents some of the world’s most design centric companies, including the top filer of U.S. design patents. He counsels a wide range of clients on strategic design protection and enforcement issues, often called upon to render infringement, validity and design-around opinions. Carani has worked with clients securing over 2,000 design rights, both in the U.S and in over 70 countries around the world. He is the current chair of the International Association for the Protection of Intellectual Property Design Rights Committee and the immediate past Chair of the American Bar Association’s Design Rights Committee, and the past chair of the American Intellectual Property Law Association’s Committee on Industrial Designs. He has litigated numerous disputes regarding design rights and has served as a legal consultant and expert witness in design law cases in a wide range of industries, including consumer electronics and accessories, consumer retail products, furniture, medical devices, apparel, footwear, and sporting goods, to name a few. In addition, Carani has authored amicus briefs for landmark U.S. design patent cases, such as Egyptian Goddess v. Swisa, Lawman Armor Corp. v. Winner Int’l LLC, Calmar, Inc. v. Arminak & Assoc. and Richardson v. Stanley Works, Inc. Carani earned an engineering degree from Marquette University and a law degree from the University of Chicago, and went on to serve as a law clerk to the Honorable Rebecca Pallmeyer at the U.S. District Court for the Northern District of Illinois. He is a registered patent attorney and licensed to practice before the USPTO.

Carani is an Adjunct Professor of Law at the Northwestern University School of Law teaching intellectual property law. He is a frequent contributor to CNN on intellectual property law issues, and is often called upon to provide commentary to other major media outlets, including New York Times, Wall Street Journal, Forbes, NPR, PBS TV, CNBC TV, BBC, Bloomberg TV, and Reuters. Away from the law, Chris is a studied jazz musician who plays upright bass on the Chicago jazz circuit. Follow Carani (@ccarani) on Twitter: